Posidur is a post-operative pain relief depot that utilizes Durect’s patented Saber technology to deliver bupivacaine and is designed to provide up to three days of pain relief after surgery.
Takeda acquired its rights to POSIDUR through its acquisition of Nycomed in September 2011.
Posidur is licensed to Hospira for commercialization in the US and Canada.
Durect retains commercialization rights for the product in the rest of the world.